pentazirinocyclodiphosphathiazene and Bright Disease

pentazirinocyclodiphosphathiazene has been researched along with Bright Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Carentz, F; Conte, JJ; Dueymes, M; Fournie, GJ; Labarre, JF; Mignon-Conte, M	1

Other Studies

1 other study(ies) available for pentazirinocyclodiphosphathiazene and Bright Disease

Article	Year
In vivo modulation of polyclonal activation of lymphocytes by SOAz, a cyclophosphazene derived drug. Prevention of murine glomerulonephritis induced by chronic injections of lipopolysaccharide. Clinical and experimental immunology, 1985, Volume: 59, Issue:1 Topics: Animals; Antigen-Antibody Complex; Azirines; B-Lymphocytes; Dose-Response Relationship, Immunologic; Female; Glomerulonephritis; Immunoglobulins; Kidney; Lipopolysaccharides; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Time Factors	1985

Article

Year

In vivo modulation of polyclonal activation of lymphocytes by SOAz, a cyclophosphazene derived drug. Prevention of murine glomerulonephritis induced by chronic injections of lipopolysaccharide.

Clinical and experimental immunology, 1985, Volume: 59, Issue:1

Topics: Animals; Antigen-Antibody Complex; Azirines; B-Lymphocytes; Dose-Response Relationship, Immunologic; Female; Glomerulonephritis; Immunoglobulins; Kidney; Lipopolysaccharides; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Time Factors

1985